Litigation Details for AstraZeneca LP v. Sigmapharm Laboratories, LLC (D. Del. 2015)
✉ Email this page to a colleague
AstraZeneca LP v. Sigmapharm Laboratories, LLC (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-10-30 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934; RE46,276 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AstraZeneca LP v. Sigmapharm Laboratories, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for AstraZeneca LP v. Sigmapharm Laboratories, LLC (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-02-21 | 165 | of multiple terms in U.S. Patent Nos. 6,525,060 ("the '060 patent") and 7,265,124 ("…construction for multiple terms in U.S. Patent Nos. 6,525,060 and 7,265,124. Signed by Judge Richard G…as U.S. Patent No. RE46,276 ("the '276 patent"). The '060 and '276 patents share …infringe five of AstraZeneca's patents. (D.I. 1). 2 The patents-in-suit claim chemical compounds as…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which | External link to document | |
| 2015-10-30 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419… 30 October 2015 1:15-cv-01000-RGA Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
